Friday, June 19, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “placebo” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 588
Total indexed 20,548
Sponsors 1,771

Quick answer

Showing 588 pipeline programs matching "placebo" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

588 results for “placebo” Back to intelligence hub

Search results

Page 15 of 25
  1. Placebo

    Acadia Pharmaceuticals B.V.

    Anxiety

    phase 2 small molecule active

    1 trial
  2. Placebo

    Cardiff Oncology

    Tuberous Sclerosis

    phase 2 small molecule active

    1 trial
  3. Placebo

    Spero Therapeutics

    Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)

    phase 2 small molecule completed

    1 trial
  4. Placebo

    RIGEL PHARMACEUTICALS INC

    Asthma

    phase 2 small molecule completed

    1 trial
  5. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine Dependence

    phase 2 small molecule completed

    2 trials
  6. Placebo

    Vistagen Therapeutics

    Healthy

    phase 2 small molecule completed

    1 trial
  7. Placebo

    Ars Pharmaceuticals Irl Limited

    Urticaria Chronic

    phase 2 small molecule active

    1 trial
  8. Placebo

    MedImmune

    Asthma

    phase 2 small molecule completed

    1 trial
  9. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    phase 2 small molecule active

    1 trial
  10. Placebo

    Vertex Pharmaceuticals (Australia) Pty.

    Rheumatoid Arthritis

    phase 2 small molecule completed

    1 trial
  11. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Bipolar Depression

    phase 2 small molecule terminated

    1 trial
  12. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Addiction

    phase 2 small molecule completed

    1 trial
  13. Placebo

    Theravance Biopharma Ireland Umited

    Crohn's Disease

    phase 2 small molecule terminated

    1 trial
  14. Placebo

    Regeneron UK Limited

    Generalized Lipodystrophy

    phase 2 small molecule completed

    1 trial
  15. Placebo

    Regeneron UK Limited

    Asthma

    phase 2 small molecule completed

    1 trial
  16. Placebo

    Theravance Biopharma Ireland Umited

    Chronic Obstructive Pulmonary Disease, COPD

    phase 2 small molecule completed

    1 trial
  17. Placebo

    LEXICON PHARMACEUTICALS, INC.

    Postherpetic Neuralgia

    phase 2 small molecule completed

    1 trial
  18. Placebo

    MapLight Therapeutics

    Schizophrenia

    phase 2 small molecule active

    1 trial
  19. Placebo

    Takeda

    Gout

    phase 2 small molecule completed

    1 trial
  20. Placebo

    Takeda

    Graft Rejection

    phase 2 mab completed

    1 trial
  21. Placebo

    Sarepta Therapeutics

    Duchenne Muscular Dystrophy

    phase 2 small molecule completed

    1 trial
  22. Placebo

    Takeda

    Celiac Disease

    phase 2 small molecule completed

    1 trial
  23. Placebo

    Takeda

    Endometriosis

    phase 2 small molecule completed

    2 trials
  24. Placebo

    Takeda

    Essential Hypertension

    phase 2 small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.